Assets تغيير تاريخ
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Acorda Therapeutics USD 364.7M 10.21M 2023-06
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Amgen USD 97.15B 6.62B 2023-12
Arrowhead Research USD 626.29M 139.27M 2023-12
Biogen USD 26.84B 1.35B 2023-12
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Cara Therapeutics USD 115.34M 19.05M 2023-09
Clal Biotechnology ILS 182.69M 6.18M 2022-12
Compugen USD 67.61M 9.44M 2023-09
CSL USD 36.23B 786.4M 2023-06
Cytokinetics USD 824.32M 83.7M 2023-12
Enanta Pharmaceuticals USD 462.28M 32.89M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Grifols EUR 22.06B 631.75M 2023-09
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Heron Therapeutics USD 229.2M 27.98M 2023-09
Insmed USD 1.33B 4.96M 2023-12
Ligand Pharmaceuticals USD 787.22M 17.99M 2023-12
MannKind USD 475.2M 154.87M 2023-12
Merck EUR 49.91B 1.12B 2023-09
Moderna USD 18.43B 1.02B 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Acorda Therapeutics الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.